Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Paroxysmal Dystonia as a Manifestation of Multiple Sclerosis
Neurologist 19:132-134, Machado, C.,et al, 2015
Isolated Lingual Dyskinesia in Multiple Sclerosis
JAMA Neurol 72:1196-1197, Park, J.E.,et al, 2015
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Movement Disorders Following Lesions of the Thalamus or Subthalamic Region
Mov Disord 9:493-507, Lee,M.S. &Marsden, C.D., 1994
Coincidence of Myoclonus and Multiple Sclerosis:Dramatic Response to Clonazepam
Neurol 40:1633-1634, Smith,C.R.&Scheinberg,L., 1990
Segmental Myoclonus Clinical and Pharmacologic Study
Arch Neurol 43:1025-1031, Jankovic,J.&Pardo,R., 1986
Dystonia & Choreoathetosis in Multiple Sclerosis
Arch Neurol 33:590, Bachman,D.S.,et al, 1976
Treatment & Prognosis of Hemiballismus
NEJM 295:1348, Klawans,H.L.,et al, 1976
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
The Useless Hand of Oppenheim
Pract Neurol 17:464-468, Wiblin, L. & Guadagno, J., 2017
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Optic Neuritis in Multiple Sclerosis: An Update
The Neurologist 6:205-213, Chan,J.W., 2000
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Ocular Torsion and Tilt of Subjective Visual Vertical are Sensitive Brainstem Signs
Ann Neurol 33:292-299, Dieterich,M.&Brandt,T., 1993
Fecal Incontinence
NEJM 326:1002-1007, Madoff,R.D.,et al, 1992
The Ocular Manifestations of Multiple Sclerosis, 2, Abnormalities of Eye Movements
JNNP 55:863-868, Barnes,D.&McDonald,W.I., 1992
Divisional Oculomotor Nerve Paresis Caused by Intrinsic Brainstem Disease
Ann Neurol 26:714-718, Ksiazek,S.M.,et al, 1989
Alternating Skew on Lateral Gaze (Bilateral Abducting Hypertropia)
Ann Neurol 23:190-192, Moster,M.L.,et al, 1988
Correlates of Brain-Stem Oculomotor Disorders in Multiple Sclerosis, Magnetic Resonance Imaging
Arch Neurol 43:460-463, Bogousslavsky,J.,et al, 1986
The Clinical Spectrum of Internuclear Ophthalmoplegia in Multiple Sclerosis
Arch Neurol 42:851-855, Muri,R.M.&Meienberg,O., 1985
The One- & -A-Half Syndrome-A Unilateral Disorder of the Pontine Tegmentum:A Study of 20 Cases & Review of the Liter
Neurol 33:971-980, Wall,M.,et al, 1983
Dorsal Midbrain Syndrome in Multiple Sclerosis
Neurol 31:196-198, Slyman,J.F.,et al, 1981
Effects of Induced Hyperthermia on Visual Evoked Potentials & Saccade Parameters in Normal Subjects & MS Pts
JNNP 43:849-852, Bajada,S.,et al, 1980
Subclinical Eye Movement Disorders in Patients with Multiple Sclerosis
Neurol 27:614, Solingen,L.D.,et al, 1977
Changes in Nystagmus on Raising Body Temperature in Clinically Suspected & Proved Multiple Sclerosis
BMJ 2:970, Jestico,J.,et al, 1976
Oculogyric Crisis
In Ocular Differential Diagnosis, Lea & Febiger, Phila. 1975 p. 133, Roy,F.H., 1975
Acquired Pendular Nystagmus with Oscillopsia in Multiple Sclerosis:A Sign of Cerebellar Nuclei Disease
JNNP 37:570, Aschoff,J.C.,et al, 1974
Narcolepsy
NEJM 288:1156, Zarcone,V., 1973
The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024
Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024
Dramatic Response to Topiramate in Acquired Pendular Nystagmus From Multiple Sclerosis
Neurol 100:47-48, Murphy,O.C. et al, 2023
Differentiating Multiple Sclerosis from AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease with Imaging
Neurol 100:e308-e323, Cortesa,R.,et al, 2023
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
Neurol 100:e1418-e1432, Cacciaguerra, L.,et al, 2023
Management of Possible Multiple Sclerosis
NEJM 388:2195-2190, , 2023
Association of Very Early treatment Initiation with the Risk of Long-Term Disability in Patients with a First Demyelinating Event
Neurol 101:e1280-e1292, 549, Cobo-Calvo,A.,et al, 2023
Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis
Neurol 97:e414-e422, Jolliffe, E.A.,et al, 2021
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021
Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021
Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020
Initial Highly Effective Therapy for MS
Neurol 95:1114-1116, Wallin, M.T., 2020
Radiologically Isolated Syndrome: A Review for Neuroradiologists
AJNR 41:1542-1549, Hosseiny, M.,et al, 2020
Two Cases of Meningitis Associated with Ocrelizumab Therapy
Mult Scler Rel Dis 38:101866, Theriault, M. & Solomon, A.J., 2020
Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis
JAMA 32:165-174,153, Burt, R.K.,et al, 2019
Simultaneous CMV and Listeria Infection Following Alemtuzumab Treatment for Multiple Sclerosis
Neurol 92:296-298, Pappolla, A.,et al, 2019
"Better Explanations" in Multiple Sclerosis Diagnostic Workup
Neurol 92:e2527-e2537, Calabrese, M.,et al, 2019
Vaccine-Preventable Infections and Immunization in Multiple Sclerosis
Neurol 93:584-594, Farez, M.F.,et al, 2019